Skip to main content
PMC home page
Gut logoLink to Gut
. 1979 May;20(5):378–384. doi: 10.1136/gut.20.5.378

Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India.

D V Datta, S K Mitra, P N Chhuttani, R N Chakravarti
PMCID: PMC1412437  PMID: 468068

Abstract

Estimates were made of the arsenic concentration in liver specimens from nine patients having idiopathic portal hypertension (IP), and in four livers these were found to be significantly higher than those in patients with cirrhosis and in control subjects. The splenovenogram revealed extensive portosystemic collateral circulation. Corrected sinusoidal pressure and blood flow studies showed higher levels in four patients than in normal subjects. Microscopic examination of liver tissues revealed periportal fibrosis. The higher hepatic arsenic levels that were found were due to the inadvertent drinking of water contaminated with arsenic, adulterated opium, and indigenous medicines. A history of opium intake was not forthcoming but two patients had drunk water contaminated with arsenic and two others had taken bhasams (Ayurvedic medicines prepared by repeated oxidation of ores). Though the aetiology of idiopathic portal hypertension is not known, it is possible that arsenic intake may be one of the factors.

Full text

PDF
381

Images in this article

380Fig. 2
on p.380
381Fig. 3
on p.381

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyer J. L., Sen Gupta K. P., Biswas S. K., Pal N. C., Basu Mallick K. C., Iber F. L., Basu A. K. Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med. 1967 Jan;66(1):41–68. doi: 10.7326/0003-4819-66-1-41. [DOI] [PubMed] [Google Scholar]
  2. CAESAR J., SHALDON S., CHIANDUSSI L., GUEVARA L., SHERLOCK S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci. 1961 Aug;21:43–57. [PubMed] [Google Scholar]
  3. Chhuttani P. N., Chawla L. S., Sharma T. D. Arsenical neuropathy. Neurology. 1967 Mar;17(3):269–274. doi: 10.1212/wnl.17.3.269. [DOI] [PubMed] [Google Scholar]
  4. Datta D. V. Arsenic in opium. Lancet. 1977 Feb 26;1(8009):484–484. doi: 10.1016/s0140-6736(77)91969-9. [DOI] [PubMed] [Google Scholar]
  5. Datta D. V., Grover S. L., Saini V. K., Datta B. N., Aikat B. K., Chhuttani P. N. Portal hypertension in chronic leukaemia. Br J Haematol. 1975 Nov;31(3):279–285. doi: 10.1111/j.1365-2141.1975.tb00859.x. [DOI] [PubMed] [Google Scholar]
  6. Datta D. V., Kaul M. K. Arsenic adulteration in opium. (Arsenicosis--a real danger to health in developing countries). Bull Narc. 1977 Jul-Sep;29(3):41–44. [PubMed] [Google Scholar]
  7. Datta D. V., Kaul M. K. Arsenic content of drinking water in villages in Northern India. A concept of arsenicosis. J Assoc Physicians India. 1976 Sep;24(9):599–604. [PubMed] [Google Scholar]
  8. Datta D. V. Letter: Arsenic and non-cirrhotic portal hypertension. Lancet. 1976 Feb 21;1(7956):433–433. doi: 10.1016/s0140-6736(76)90282-8. [DOI] [PubMed] [Google Scholar]
  9. Datta D. V. Non-cirrhotic portal fibrosis ('idiopathic' portal hypertension in India). J Assoc Physicians India. 1976 Aug;24(8):511–527. [PubMed] [Google Scholar]
  10. FRANKLIN M., BEAN W. B., HARDIN R. C. Fowler's solution as an etiologic agent in cirrhosis. Am J Med Sci. 1950 Jun;219(6):589–596. doi: 10.1097/00000441-195006000-00001. [DOI] [PubMed] [Google Scholar]
  11. Huet P. M., Guillaume E., Cote J., Légaré A., Lavoie P., Viallet A. Noncirrhotic presinusoidal portal hypertension associated with chronic arsenical intoxication. Gastroenterology. 1975 May;68(5 Pt 1):1270–1277. [PubMed] [Google Scholar]
  12. Mahajan R. C., Dutta D. V. Malarial antibody studies in non-cirrhotic portal fibrosis-a preliminary observation. Indian J Med Res. 1976 May;64(5):652–655. [PubMed] [Google Scholar]
  13. Mallik K. C., Sen Gupta K. P., Basu A. K., Biswas S. K., Pal N. C., Boyer J. Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. II. Histopathological studies. Indian J Med Res. 1967 Apr;55(4):351–359. [PubMed] [Google Scholar]
  14. Morris J. S., Schmid M., Newman S., Scheuer P. J., Sherlock S. Arsenic and noncirrhotic portal hypertension. Gastroenterology. 1974 Jan;66(1):86–94. [PubMed] [Google Scholar]
  15. RAMALINGASWAMI V., WIG K. L., SAMA S. K. Cirrhosis of the liver in northern India. A clinicopathologic study. Arch Intern Med. 1962 Sep;110:350–358. doi: 10.1001/archinte.1962.03620210074014. [DOI] [PubMed] [Google Scholar]
  16. Rosenberg H. G. Systemic arterial disease and chronic arsenicism in infants. Arch Pathol. 1974 Jun;97(6):360–365. [PubMed] [Google Scholar]
  17. Sama S. K., Bhargava S., Nath N. G., Talwar J. R., Nayak N. C., Tandon B. N., Wig K. L. Noncirrhotic portal fibrosis. Am J Med. 1971 Aug;51(2):160–169. doi: 10.1016/0002-9343(71)90234-8. [DOI] [PubMed] [Google Scholar]
  18. Villeneuve J. P., Huet P. M., Joly J. G., Marleau D., Côté J., Légaré A., Lafortune M., Lavoie P., Viallet A. Idiopathic portal hypertension. Am J Med. 1976 Oct;61(4):459–464. doi: 10.1016/0002-9343(76)90323-5. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES